PSYCHEMEDICS CORPORATION CMN - COM (PMD) Institutional Ownership

CUSIP: 744375205

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2025

Type / Class
Equity / COM
Symbol
PMD on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$643,159 0
2025 Q1 276,034 $643,159 +$598,159 $2.33 1
2024 Q4 20,000 $45,000 -$2,801,487 $2.25 1
2024 Q3 1,232,566 $2,847,487 +$114,459 $2.31 21
2024 Q2 1,186,826 $2,872,367 -$54,190 $2.42 25
2024 Q1 1,209,082 $3,542,861 -$240,962 $2.93 21
2023 Q4 1,290,527 $3,819,693 -$537,146 $2.96 22
2023 Q3 1,431,884 $5,683,476 +$174,775 $3.97 24
2023 Q2 1,384,665 $6,314,481 -$59,621 $4.56 21
2023 Q1 1,397,701 $7,339,631 -$73,851 $5.25 20
2022 Q4 1,411,795 $6,927,008 -$367,485 $4.91 21
2022 Q3 1,479,435 $9,540,000 -$129,704 $6.45 20
2022 Q2 1,500,349 $9,550,000 -$610,521 $6.34 19
2022 Q1 1,612,697 $10,966,000 -$96,982 $6.90 23
2021 Q4 1,627,556 $11,405,000 -$641,406 $7.00 22
2021 Q3 1,657,014 $13,948,000 -$1,066,411 $8.40 25
2021 Q2 1,782,619 $12,408,000 -$502,624 $6.96 23
2021 Q1 1,860,137 $11,533,000 -$919,032 $6.20 25
2020 Q4 2,037,748 $10,373,000 -$1,125,736 $5.09 28
2020 Q3 2,276,746 $10,039,000 -$1,513,421 $4.41 28
2020 Q2 2,604,753 $14,426,387 -$107,408 $5.54 29
2020 Q1 2,625,592 $15,885,757 -$288,113 $6.05 32
2019 Q4 2,635,161 $24,111,111 +$146,207 $9.15 38
2019 Q3 2,615,737 $23,832,480 -$2,615,686 $9.11 39
2019 Q2 2,816,210 $28,409,688 -$4,519,146 $10.09 43
2019 Q1 3,174,281 $44,544,609 +$813,365 $14.03 48
2018 Q4 3,113,635 $49,409,952 -$629,297 $15.87 52
2018 Q3 3,084,784 $58,022,198 +$2,027,408 $18.81 52
2018 Q2 3,034,881 $58,438,992 -$443,562 $19.24 50
2018 Q1 3,056,434 $64,872,488 +$85,284 $21.36 50
2017 Q4 3,053,934 $62,780,680 -$1,374,542 $20.56 45
2017 Q3 3,148,618 $58,022,665 -$1,735,944 $18.43 50
2017 Q2 3,180,778 $79,351,725 +$5,529,441 $24.95 57
2017 Q1 2,948,981 $59,254,000 +$145,273 $20.05 53
2016 Q4 2,926,838 $72,116,700 -$3,495,271 $24.68 52
2016 Q3 3,071,257 $60,972,550 -$2,717,050 $19.82 44
2016 Q2 3,222,955 $44,274,480 -$566,049 $13.74 32
2016 Q1 3,289,908 $45,250,500 +$460,545 $13.75 33
2015 Q4 3,260,028 $33,046,146 +$731,610 $10.14 34
2015 Q3 3,188,141 $32,074,020 +$1,534,813 $10.05 35
2015 Q2 2,997,424 $44,441,595 -$1,039,858 $14.83 35
2015 Q1 2,722,206 $45,056,996 +$1,157,064 $16.59 36
2014 Q4 2,653,700 $40,166,575 +$1,024,704 $15.15 36
2014 Q3 2,593,293 $36,784,720 +$1,441 $14.16 33
2014 Q2 2,593,171 $36,716,234 -$570,200 $14.16 38
2014 Q1 2,606,778 $44,593,005 -$496,479 $17.13 35